(1) A 1,3-thiazole compound of which the 5-position is substituted with a
4-pyridyl group having a substituent including no aromatic group or (2) a
1,3-thiazole compound of which the 5-position is substituted with a
pyridyl group having at the position adjacent to a nitrogen atom of the
pyridyl group a substituent including no aromatic group has an excellent
p38 MAP kinase inhibitory activity.